Big data collaboration to improve chronic disease management

August 03, 2015

Duke-NUS Graduate Medical School Singapore (Duke-NUS) and Holmusk, a global tele-health platform, have recently announced a collaboration to further the potential of big data in healthcare. Big data refers to very large, unstructured and diverse datasets that cannot be managed using conventional methods. In healthcare, big data and analytics allow us to discover patterns that would not be found otherwise, and make predictions about disease. This has the potential to improve care and lower costs.

The collaboration will focus on addressing ways to improve care management for diabetes and mental health. The aim is to leverage information collected from personal health records, medical and fitness devices, as well as more traditional sources of health data such as medical records, claims data and clinical research. The result will be a new generation of tools that offer better insights, real-time feedback and recommendations. These will enable physicians and patients to make timely, evidence-based and personalised decisions about health and disease management.

"We are excited to be contributing to the healthcare IT space in Singapore," said Professor David Epstein, Director of Duke-NUS' Centre for Technology and Development. "With the decision-making tools that will come from this collaboration, it will be possible for hospitals and doctors to adopt a more patient-centric approach to determining the necessity, extent and timing for particular treatments."

"We're looking forward to helping develop and evaluate tools that can be applied in the hospital setting to cost effectively improved delivery of patient services," said Professor Eric Finkelstein from the Health Services and Systems Research Programme at Duke-NUS. Professor Finkelstein will be overseeing the collaboration with Holmusk on the Duke-NUS campus. His research focuses on health technology assessment and the use of incentives to influence health behaviours.

"From banking to retail, many sectors have already embraced big data," said Nawal Roy, CEO and founder of Holmusk. "We're still in the early days of the big data revolution in healthcare. With this collaboration, we can help to transform the way we manage health. By putting powerful and accurate decision support tools into the hands of patients and doctors, we can make the system more efficient, cost-effective and data-driven. Ultimately, we want to improve patient outcomes."
-end-


Duke-NUS Medical School

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.